Shareholders Seek Class Cert. In Teva Price-Fixing Suit
Shareholders accusing Teva Pharmaceutical Industries Ltd. of operating a price-fixing scheme and lying about profit growth have asked a Connecticut federal judge to certify their proposed class, arguing that they easily...To view the full article, register now.
Already a subscriber? Click here to view full article